Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Enveric Biosciences Inc
(NQ:
ENVB
)
0.4820
-0.0080 (-1.63%)
Streaming Delayed Price
Updated: 3:13 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enveric Biosciences Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Nasdaq Drops 100 Points; Crude Oil Rises Sharply
July 25, 2022
U.S. stocks traded mostly lower toward the end of trading on Monday.
Via
Benzinga
Dow Rises Over 100 Points; Revelation Biosciences Shares Spike Higher
July 25, 2022
U.S. stocks traded mostly higher midway through trading on Monday.
Via
Benzinga
Why Is Infrastructure and Energy Alternatives Higher By Around 29%? 37 Stocks Moving In Monday's Mid-Day Session
July 25, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 104% to $1.3263 after the company announced that primary endpoint was met in study for its treatment of allergic rhinitis.
Via
Benzinga
Why U.S. Stocks Are Trading Mostly Higher; Chicago Fed National Activity Index Remains Unchanged
July 25, 2022
U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 100 points on Monday.
Via
Benzinga
Enveric Biosciences Stock Is Nosediving Today: What's Happening?
July 25, 2022
Enveric Biosciences Inc (NASDAQ: ENVB) shares are trading lower by 21.84% to $7.55 Monday morning after the company announced an $8 million registered direct offering and private placement.
Via
Benzinga
Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact
July 25, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
11 Health Care Stocks Moving In Monday's Pre-Market Session
July 25, 2022
Via
Benzinga
Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules
July 25, 2022
From
Enveric Biosciences, Inc.
Via
Business Wire
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
July 25, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 22, 2022
Via
Benzinga
Enveric Biosciences Announces Formation of Scientific Advisory Board to Drive Further Growth of Next-Generation Mental Health Medicines
July 19, 2022
From
Enveric Biosciences, Inc.
Via
Business Wire
The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate
July 15, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 14, 2022
Via
Benzinga
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday
July 15, 2022
Gainers
Via
Benzinga
Enveric Biosciences Announces Reverse Stock Split
July 14, 2022
From
Enveric Biosciences, Inc.
Via
Business Wire
Psychedelic Companies With Solid Fundamentals Will Survive A Downturn In The Recession-Ridden Market
July 13, 2022
Article by Jason Najum. Psychedelic startups face a more challenging time raising capital amid market volatility, the prospect of rate hikes, and recession fears, but that could ultimately help the...
Via
Benzinga
Enveric Biosciences Advances Drug Development for Mental Health Indications and Intellectual Property Portfolio
July 13, 2022
From
Enveric Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 12, 2022
Via
Benzinga
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
July 11, 2022
Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
July 11, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 30, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 28, 2022
Via
Benzinga
10 Psychedelics CEOs To Pay Attention To In 2022
June 22, 2022
By Javier Hasse and Aaron Bry. 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both...
Via
Benzinga
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
June 30, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022
June 01, 2022
Upgrades
Via
Benzinga
Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies
May 17, 2022
The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 11, 2022
Via
Benzinga
EXCLUSIVE: NASDAQ-Listed Enveric To Split Into Two Companies, One For Cannabinoids, One For Psychedelics
May 11, 2022
Enveric Biosciences (NASDAQ: ENVB), a biotech company working with cannabinoids and psychedelics, announced it will spin off its cannabinoid pipeline into a separate public company that will also be...
Via
Benzinga
American Billionaire Entrepreneurs Bet Millions on Psychedelics
May 10, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – May 10, 2022 – Billionaire Bob Parsons, the founder of GoDaddy, believes psychedelics can heal trauma. The Marine infantryman...
Via
FinancialNewsMedia
Exposures
Product Safety
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
April 25, 2022
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.